Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis

Am J Gastroenterol. 2006 Nov;101(11):2664-5. doi: 10.1111/j.1572-0241.2006.00809_3.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / chemically induced*
  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Cecal Neoplasms / chemically induced
  • Cholangitis, Sclerosing / surgery*
  • Colonic Neoplasms / chemically induced*
  • Crohn Disease / drug therapy*
  • Gastrointestinal Agents / adverse effects*
  • Humans
  • Infliximab
  • Liver Transplantation*
  • Male
  • Postoperative Complications

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab